Hide Board Information

Show Board Information

Alpha Modus Holdings, Inc. AMOD

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/01/2025 9:23:02 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 7

Alpha Modus Holdings, Inc. (NASDAQ: AMOD) Stock Message Board

1. AMOD Company Profile

    

2. AMOD Time & Sales

    

3. AMOD Recent News

    

4. AMOD Filings

    

5. AMOD Financials

    

6. AMOD Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

11	Alpha Modus Holdings Enters into Funding	Lee Adams	05/01/2025 9:23:02 AM
10	$AMOD News: Alpha Modus Secures Landmark	Lee Adams	03/17/2025 10:09:44 AM
9	$AMOD featured here: From Innovating To	Lee Adams	03/04/2025 11:56:22 AM
8	Alpha Modus Holdings Inc. (NASDAQ: AMOD) Rings	Lee Adams	02/18/2025 11:19:34 AM
7	Alpha Modus (Nasdaq: AMOD) Announces AI-Powered	Lee Adams	02/13/2025 9:13:33 AM
6	$AMOD News: Alpha Modus Announces Strategic (1)	Lee Adams	02/10/2025 9:34:16 AM
5	$AMOD News: Alpha Modus Sues Walgreens for Patent	Lee Adams	02/04/2025 9:41:38 AM
4	Alpha Modus Appoints Accomplished Executive	Lee Adams	01/22/2025 3:35:12 PM
3	Alpha Modus Secures 9th AI Patent, Strengthening	Lee Adams	01/22/2025 3:33:44 PM
2	Alpha Modus Files Patent Infringement Lawsuit	Lee Adams	01/22/2025 3:32:14 PM
1	Alpha Modus and Insight Acquisition Corp Close	Lee Adams	01/22/2025 3:30:45 PM

Recent Articles

• Empowering Youth: The Launch of a New Learning Platform
• Trump Media's Significant Growth and Strategic Expansion Insights
• ThreeD Capital Inc. Joins Forces with Inwentash on Digital Asset Strategy
• Annexon Highlights Tanruprubart Advancements for GBS Treatment
• Tragic Incident at Orezone Gold’s Construction Site
• Cornerstone Funds Continue Monthly Distributions for Shareholders
• Celebrating Excellence in Maternal Health Resources for Moms
• Transforming Neighborhoods: Purpose Built Communities Conference Success
• Tim Tebow Inspires at Florida Southern's Mother's Day Event
• Understanding Fulcrum Therapeutics' Recent Stock Option Grant
• Olema Oncology Highlights Investor Conference Participation Plans
• Vital Battery Metals Transitions to Aventis Energy Inc. Name Change
• Exploring Herzfeld Caribbean Basin Fund's Stock and Cash Strategy
• Summary of Source Energy Services Annual Meeting Outcomes
• Preferred Bank Welcomes New Leadership in Risk Management
• Lockheed Martin's Significant 2025 Dividend Announcement
• Vulcan Announces Cash Dividend for Common Stock Investors
• Leadership Updates at Steel Dynamics Craft Future Success
• Tactacam Teams Up with Barrett for Enhanced Fulfillment Solutions
• Coave Therapeutics Unveils coAAV-CSF-01: A Breakthrough in CNS Gene Therapy
• Nyxoah SA Reports New Transparency Notification Updates
• Twin Disc Inc. Declares New Dividend for Shareholders
• BioCardia Set to Share Key Updates and Financial Insights in 2025
• Exploring the Recent Class Action Against West Pharmaceutical Services
• Nortech Systems to Share Q1 2025 Financial Insights Soon
• Avenue Capital Group Responds to Recent Lawsuit Claims
• Denali Capital's New Deadline for Business Combination Explained
• Nauticus Robotics Sets Date for Q1 Earnings Conference Call
• BNY Mellon to Showcase Q2 2025 Financial Results
• Parks! America, Inc. Posts Strong Q2 Performance Results
• TDS to Host Live Stream of 2025 Shareholder Meeting Soon
• Navigator Gas Board Update: A Transition in Leadership
• Hamilton Beach Brands Boosts Dividend for Shareholders
• Mayors Unite Against Medicaid Cuts to Protect Public Safety
• NI Holdings, Inc. Achieves Steady Growth in Q1 Results
• Navigator Gas Sets 2025 Meeting to Shape Its Future Strategies
• Investor Rights Investigation on TaskUs, ProAssurance, and Mr. Cooper
• Okeanis Eco Tankers Corp. Q1 2025 Results Overview
• Volcon Inc. Showcases Growth and Financial Performance Insights
• Artisan Partners Asset Management Sees Growth in AUM to $164.4B
• Fancamp's New Settlement Deal and Growth Opportunities Ahead
• Replimune's Strategic Inducement Awards for New Talent Acquisition
• PDS Biotechnology's Stock Option Grant and Strategic Plans Ahead
• Vera Therapeutics Announces New Employee Stock Awards
• Exagen's Public Offering Success: $20.2 Million Raised for Growth
• 89bio's Strategic Employee Inducement Grants Enhancing Growth Potential
• Analyzing Nasdaq's Latest Short Interest Data and Trends
• Matador Technologies Introduces New Private Placement Funding
• Athira Pharma's Q1 2025 Financial Outcomes and Pipeline Insights
• Entera Bio Posts Strong First Quarter 2025 Results and Updates